Post COVID-19 syndrome is clinically defined as "signs or symptoms that develop during or after an infection consistent with COVID-19, continue for more than 12 weeks and are not explained by an alternative diagnosis." Understanding the prevalence of post-Covid syndrome in the population is an important part of planning for national recovery from the pandemic, as well as understanding likely future health needs. This area of work is ongoing. If you are a volunteer interested in joining this review, or an external organisation interested in partnering with UNCOVER, please get in touch with us.
Summary: What is the Prevalence of the Post COVID-19 Syndrome (Defined as Having Signs and Symptoms 12 Weeks Post the Acute Phase of the Infection)?
By: Theodoratou, E., McQuillan, R., Curry, G., Dong, Y., Dozier, M., Goodwin, L., Farfan de los Godos, E., Iduye, D., Kirolos, A., Krishan, P., McSwiggan, E., Nundy, M., Rostron, J., Xu, W., Zhang, Z.
If you are interested in completing an extended project or Masters dissertation on a related topic, UNCOVER may be able to offer practical support, (co-)supervision and/or peer mentorship. Please contact our Project Manager for more information.
| Professor Evropi Theodoratou | Review Co-Lead | View Profile |
| Dr Ruth McQuillan | Review Co-Lead | View Profile |
| Marshall Dozier | Information Specialist | View Profile |
| Dr Gwenetta Curry | Review Team | View Profile |
| Yijia Dong | Review Team | |
| Lara Goodwin | Review Team | |
| Emma Farfan de los Godos | Review Team | |
| Damilola Iduye | Review Team | |
| Dr Amir Kirolos | Review Team | View Profile |
| Dr Prerna Krishan | Review Team | |
| Emilie McSwiggan | Review Team | View Profile |
| Dr Madhurima Nundy | Review Team | |
| Jasmin Rostron | Review Team | |
| Wei Xu | Review Team | |
| Xiaomeng Zhang | Review Team | |
| Dr Nazir Lone | Advisor | View Profile |
| Professor Gerry Fowkes | Advisor | View Profile |
| Professor Harry Campbell | Advisor | View Profile |